stacking tirzepatide and semaglutide GLP-1 stacking?! What happens when you combine with Tirzep... | stack STACKING DOSES EXPLAINED (Semaglutide/Tirzepatide)

The FLOW trial (Evaluate Renal Function with Semaglutide Once Weekly) is the first designed to assess the effect of a GLP-1RA on primary composite kidney outcomes among patients with CKD and type 2 diabetes (T2DM)

The vision loss from NAION is typically permanent, and there is currently no effective treatment to restore it

Muscle protein is one source

The HR for NAION among new users of semaglutide was not different compared with that of the non-GLP-1 receptor agonist drugs using the sensitive NAION definitionempagliflozin (HR: 1.44), sitagliptin (HR: 1.30), and glipizide (HR: 1.23)

patients to speak with their healthcare providers for an accurate risk assessment